196 related articles for article (PubMed ID: 29243347)
1. Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD.
Huber MB; Präger M; Coyle K; Coyle D; Lester-George A; Trapero-Bertran M; Nemeth B; Cheung KL; Stark R; Vogl M; Pokhrel S; Leidl R
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):52-64. PubMed ID: 29243347
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD.
Németh B; Józwiak-Hagymásy J; Kovács G; Kovács A; Demjén T; Huber MB; Cheung KL; Coyle K; Lester-George A; Pokhrel S; Vokó Z
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):76-86. PubMed ID: 29368363
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD.
Trapero-Bertran M; Muñoz C; Coyle K; Coyle D; Lester-George A; Leidl R; Németh B; Cheung KL; Pokhrel S; Lopez-Nicolás Á
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):65-75. PubMed ID: 29532966
[TBL] [Abstract][Full Text] [Related]
4. Assessment of cost-effective changes to the current and potential provision of smoking cessation services: an analysis based on the EQUIPTMOD.
Anraad C; Cheung KL; Hiligsmann M; Coyle K; Coyle D; Owen L; West R; de Vries H; Evers SM; Pokhrel S
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):96-105. PubMed ID: 29430762
[TBL] [Abstract][Full Text] [Related]
5. Estimates of costs for modelling return on investment from smoking cessation interventions.
Trapero-Bertran M; Leidl R; Muñoz C; Kulchaitanaroaj P; Coyle K; Präger M; Józwiak-Hagymásy J; Cheung KL; Hiligsmann M; Pokhrel S;
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):32-41. PubMed ID: 29532538
[TBL] [Abstract][Full Text] [Related]
6. Is it cost-effective to provide internet-based interventions to complement the current provision of smoking cessation services in the Netherlands? An analysis based on the EQUIPTMOD.
Cheung KL; Wijnen BFM; Hiligsmann M; Coyle K; Coyle D; Pokhrel S; de Vries H; Präger M; Evers SMAA
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):87-95. PubMed ID: 29243351
[TBL] [Abstract][Full Text] [Related]
7. Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation.
Coyle K; Coyle D; Lester-George A; West R; Nemeth B; Hiligsmann M; Trapero-Bertran M; Leidl R; Pokhrel S;
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):7-18. PubMed ID: 28833765
[TBL] [Abstract][Full Text] [Related]
8. Estimates of effectiveness and reach for 'return on investment' modelling of smoking cessation interventions using data from England.
West R; Coyle K; Owen L; Coyle D; Pokhrel S;
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):19-31. PubMed ID: 28833834
[TBL] [Abstract][Full Text] [Related]
9. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
Ekpu VU; Brown AK
Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
[TBL] [Abstract][Full Text] [Related]
10. Are financial incentives cost-effective to support smoking cessation during pregnancy?
Boyd KA; Briggs AH; Bauld L; Sinclair L; Tappin D
Addiction; 2016 Feb; 111(2):360-70. PubMed ID: 26370095
[TBL] [Abstract][Full Text] [Related]
11. Cost-benefit analysis of funding smoking cessation before surgery.
Jiménez-Ruiz CA; Martín V; Alsina-Restoy X; de Granda-Orive JI; de Higes-Martínez E; García-Rueda M; Genovés-Crespo M; López-García C; Lorza-Blasco JJ; Márquez FL; Ramos-Pinedo Á; Riesco-Miranda JA; Signes-Costa J; Solano-Reina S; Vaquero-Lozano P; Rejas J
Br J Surg; 2020 Jul; 107(8):978-994. PubMed ID: 32372474
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
[TBL] [Abstract][Full Text] [Related]
13. Healthcare financing systems for increasing the use of tobacco dependence treatment.
van den Brand FA; Nagelhout GE; Reda AA; Winkens B; Evers SMAA; Kotz D; van Schayck OC
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD004305. PubMed ID: 28898403
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.
Hoogendoorn M; Welsing P; Rutten-van Mölken MP
Curr Med Res Opin; 2008 Jan; 24(1):51-61. PubMed ID: 18021492
[TBL] [Abstract][Full Text] [Related]
15. Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke.
Mundt MP; Baker TB; Fraser DL; Smith SS; Piper ME; Fiore MC
Value Health; 2019 Feb; 22(2):177-184. PubMed ID: 30711062
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.
Taylor M; Leonardi-Bee J; Agboola S; McNeill A; Coleman T
Addiction; 2011 Oct; 106(10):1819-26. PubMed ID: 21561499
[TBL] [Abstract][Full Text] [Related]
17. Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.
Coleman T; Agboola S; Leonardi-Bee J; Taylor M; McEwen A; McNeill A
Health Technol Assess; 2010 Oct; 14(49):1-152, iii-iv. PubMed ID: 21040645
[TBL] [Abstract][Full Text] [Related]
18. Investigating the cost-effectiveness of three cessation interventions on a national scale using the Economics of Smoking in Pregnancy (ESIP) decision analytical model.
Jones M; Smith M; Lewis S; Parrott S; Coleman T
Addiction; 2022 Nov; 117(11):2907-2917. PubMed ID: 35661312
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness Analysis of Smoking Cessation Interventions in Japan Using a Discrete-Event Simulation.
Igarashi A; Goto R; Suwa K; Yoshikawa R; Ward AJ; Moller J
Appl Health Econ Health Policy; 2016 Feb; 14(1):77-87. PubMed ID: 26597111
[TBL] [Abstract][Full Text] [Related]
20. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
Keating GM; Lyseng-Williamson KA
Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
